EIF4E and acute myeloid leukemia: They found that treatment of AML cells with cercosporamide resulted in dose-dependent suppression of eIF4E phosphorylation and that the combination of cercosporamide with cytarabine resulted in enhanced antileukemic responses in a xenograft mouse model in vivo [57].